VisionHealth raises 3 million Euro to finance extended COPD and asthma study for market preparation of Kata®, an innovative digital therapeutic for improved inhalation  DB Speciality Invest, an investment firm of Dr. Dietrich Bruchmann, invests in VisionHealth   Funds will be used for EU and U.S. regulatory approval and commercial launch

Nagarjun Anantha Padmanabha has been part of the VisionHealth team for four years. As Head of Software Development, he has a lot of responsibilities and a varied scope of duties. This includes, but is not limited to, organizing and leading development teams in the creation of software products, planning, scheduling,

VisionHealth’s Kata® Clinical to be included into Alcedis service platform for clinical studies Kata® Clinical app supports clinical trials in the field of chronic lung diseases and can be customized to each trial’s individual requirements Based on artificial intelligence (AI), Kata® Clinical can improve both study outcomes and participants’ experience